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Abstract
Background
The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established
in 2007 by the World Health Organization to estimate the global burden of foodborne dis-
eases (FBDs). This paper describes the methodological framework developed by FERG's
Computational Task Force to transform epidemiological information into FBD burden
estimates.
Methods and Findings
The global and regional burden of 31 FBDs was quantified, along with limited estimates for
5 other FBDs, using Disability-Adjusted Life Years in a hazard- and incidence-based
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approach. To accomplish this task, the following workflow was defined: outline of disease
models and collection of epidemiological data; design and completion of a database tem-
plate; development of an imputation model; identification of disability weights; probabilistic
burden assessment; and estimating the proportion of the disease burden by each hazard
that is attributable to exposure by food (i.e., source attribution). All computations were per-
formed in R and the different functions were compiled in the R package 'FERG'. Traceability
and transparency were ensured by sharing results and methods in an interactive way with
all FERGmembers throughout the process.
Conclusions
We developed a comprehensive framework for estimating the global burden of FBDs, in
which methodological simplicity and transparency were key elements. All the tools devel-
oped have been made available and can be translated into a user-friendly national toolkit
for studying and monitoring food safety at the local level.
Introduction
The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established in
2007 by the World Health Organization (WHO) to estimate the global burden of foodborne
diseases (FBDs) [1]. In 2012, FERG established a Computational Task Force (CTF) to derive
FBD burden estimates using epidemiological information generated by the hazard-based and
source attribution task forces [2]. The aim of this paper is to describe the methodological
framework developed by the CTF for this task.
Variation in methodological choices has been identified both in general and in foodborne-
specific burden of disease studies, impeding comparability of burden estimates across studies
[3,4]. To ensure accuracy, utility and comparability with other existing health metric initiatives,
FERG decided to quantify the burden of FBDs in terms of Disability-Adjusted Life Years
(DALYs), a health gap measure expressing the number of healthy life years lost due to reduc-
tion of health and death. Further methodological choices were discussed during the fourth for-
mal meeting of FERG in 2010 [5], and confirmed at the FERG Strategic Planning Meeting in
2011 and at the fifth FERG meeting in 2013 [6,7]. The main methodological decision was that
DALYs were to be calculated in a hazard- and incidence-based approach [8].
Building on the FERG approach, the CTF tasks were (1) to develop the necessary tools for
DALY calculation and (2) to implement these tools for estimating the burden of 36 FBDs,
including 21 enteric diseases caused by bacteria, viruses and protozoa, 11 non-enteric parasitic
diseases, and 4 diseases caused by chemicals and toxins.
In this paper, we (1) describe the approach taken for quantifying the burden of FBD; (2)
describe the steps and methodological choices to calculate DALYs resulting from FBDs; (3)
describe traceability and transparency during the process; and (4) discuss limitations and
future directions. All tools that were developed by the CTF are available as Supporting Infor-
mation, allowing the reader to access, explore and use these different tools.
Hazard- and Incidence-Based DALY Approach
Strong and reliable burden of disease estimates are crucial for setting priorities in public health
and biomedical research [9,10]. Ranking disease impact may be based on disease occurrence
WHO/FERGMethodological Framework
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(prevalence or incidence) or on the number of deaths (mortality). However, these simple mea-
sures of population health do not provide a full picture of the impact of specific diseases on
human health. Indeed, while certain diseases may be very common, their clinical impact may
be limited. Infection with a highly prevalent parasite such as Enterobius vermicularis (also
known as pinworm or threadworm) for instance has a very low burden because most of the
cases are mild to asymptomatic and self-limiting [11]. Likewise, ignoring the age at which peo-
ple die, and thus not considering how many years of healthy life might be lost due to a prema-
ture death does not fairly capture the impact of mortality. Disease severity, defined by the
health impact and duration of the concerned symptoms and the life expectancy at the age of
death, should thus also be taken into account when quantifying burden of disease. Further-
more, simple measures of population health do not combine the impacts of morbidity and
mortality. This prohibits a comparative ranking of highly morbid, but not necessarily fatal dis-
eases such as chorioretinitis and highly lethal diseases such as liver cancer, complicating deci-
sions on resource allocation priorities.
To overcome the limitations of simple measures of population health, summary measures
of population health (SMPHs) have been developed as an additional source of information for
measuring disease burden. Among these SMPHs, the Disability-Adjusted Life Year (DALY) is
currently the most widely used in public health research. Originally developed to quantify and
compare the burden of diseases, injuries and risk factors across countries, the DALY summa-
rizes the occurrence and impact of morbidity and mortality in a single measure [12,13]. The
DALY is the key measure in the Global Burden of Disease (GBD) studies and is officially
adopted by WHO for reporting on health information [14,15].
The DALY is a health gap measure. It measures the healthy life years lost due to a disease or
injury. DALYs are calculated by adding the adjusted number of years lived with disability
(YLDs) and the number of years of life lost due to premature mortality (YLLs):
YLD = Number of incident cases x Duration until remission or death x Disability Weight
YLL = Number of deaths x Residual life expectancy at the age of death
Different approaches can be taken for calculating DALYs, depending on whether the inter-
est lies in quantifying the burden of a health outcome (such as diarrhea), a hazard (as defined
by the Codex Alimentarius Commission, e.g. a biological agent that may cause illness in
humans such as Salmonella enterica), or a risk factor (e.g. an exposure that increases the likeli-
hood of illness such as unsafe water) [16]. Since FERG is concerned with the burden of FBDs,
which are caused by a wide range of hazards (bacteria, viruses, parasites, chemicals, and tox-
ins), a natural choice is the hazard-based approach. This approach defines the burden of a spe-
cific foodborne hazard as that resulting from the health states, i.e., symptoms and sequelae,
including death, that are causally related to the concerned hazard transmitted through food,
and which may become manifest at different time scales or have different severity levels [8].
This approach thus allows for a comprehensive estimate of the burden of disease due to a cer-
tain hazard, including sequelae, which may have a higher burden than acute illness alone [17–
19]. Table 1 shows the hazards and related health states that were included in FERG's global
burden of FBD estimates.
DALYs, and more specifically their YLD component, may be calculated from an incidence
or a prevalence perspective. While incidence-based YLDs are defined as the product of the
number of incident cases and the duration and disability weight (DW) of the concerned health
state, prevalence-based YLDs are defined as the product of the number of prevalent cases and
the corresponding DW [13,14]. In the incidence-based approach, all health outcomes, includ-
ing those in future years, are assigned to the initial event (e.g. exposure to a certain hazard).
This approach therefore reflects the future burden of disease resulting from current events. In
the prevalence-based approach, on the other hand, the health status of a population is assessed
WHO/FERGMethodological Framework
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Table 1. FERG hazards, causally related health states and corresponding disability weights (DWs). Details on the derivation of the DWs are provided
in S2 Table.
Hazard Health state DW
Diarrheal disease agents
Norovirus Diarrheal disease a 0.074
Campylobacter spp. Diarrheal disease a 0.101
Guillain-Barré syndrome 0.445
Enteropathogenic E. coli Diarrheal disease a 0.074
Enterotoxigenic E. coli Diarrheal disease a 0.074
Shiga toxin-producing E. coli Diarrheal disease a 0.091
Hemolytic uremic syndrome 0.210
End-stage renal disease 0.573
Non-typhoidal S. enterica Diarrheal disease a 0.101
Invasive salmonellosis 0.210
Shigella spp. Diarrheal disease a 0.101
Vibrio cholerae Diarrheal disease a 0.194
Cryptosporidium spp. Diarrheal disease a 0.074
Entamoeba histolytica Diarrheal disease a 0.074
Giardia spp. Diarrheal disease a 0.074
Invasive infectious disease agents
Hepatitis A Virus Hepatitis 0.108
Brucella spp. Acute brucellosis 0.108
Chronic brucellosis 0.079
Orchitis 0.097
Listeria monocytogenes, perinatal Sepsis 0.210
Central nervous system infection 0.426
Neurological sequelae 0.292
Listeria monocytogenes, acquired Sepsis 0.210
Central nervous system infection 0.426
Neurological sequelae 0.292
Mycobacterium bovis Tuberculosis 0.331
Salmonella Paratyphi Paratyphoid fever 0.210
Liver abscesses and cysts 0.254
Salmonella Typhi Typhoid fever 0.210
Liver abscesses and cysts 0.254
Toxoplasma gondii, congenital Intracranial calcification 0.010
Hydrocephalus 0.360
Chorioretinitis, early in life 0.033
Chorioretinitis, later in life 0.033
CNS abnormalities 0.360
Toxoplasma gondii, acquired Chorioretinitis, mild 0.004
Chorioretinitis, moderate 0.033
Chorioretinitis, severe 0.191
Acute illness 0.053
Post-acute illness 0.254
Enteric intoxications
Bacillus cereus b Acute intoxication 0.061
Clostridium botulinum b Moderate/mild botulism 0.198
Severe botulism 0.445
(Continued)
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at a specific point in time, and prevalent diseases are attributed to initial events that happened
in the past. This approach therefore reflects the current burden of disease resulting from previ-
ous events. For burden of FBD studies, the incidence-based YLD approach was deemed the
most appropriate approach, because (1) this approach is more sensitive to current
Table 1. (Continued)
Hazard Health state DW
Clostridium perfringens b Acute intoxication 0.061
Staphylococcus aureus b Acute intoxication 0.061
Cestodes
Echinococcus granulosus, cases seeking treatment Pulmonary cystic echinococcosis 0.192
Hepatic cystic echinococcosis 0.123
Central nervous system cystic echinococcosis 0.221
Echinococcus granulosus, cases not seeking treatment Pulmonary cystic echinococcosis 0.015
Hepatic cystic echinococcosis 0.012
Central nervous system cystic echinococcosis 0.054
Echinococcus multilocularis Alveolar echinococcosis 0.123
Taenia solium Epilepsy: treated, seizure free 0.072
Epilepsy: treated, with recent seizures 0.319
Epilepsy: severe 0.657
Epilepsy: untreated 0.420
Nematodes
Ascaris spp. Ascariasis infestation 0.030
Mild abdominopelvic problems due to ascariasis 0.012
Severe wasting due to ascariasis 0.127
Trichinella spp. Acute clinical trichinellosis 0.637
Trematodes
Clonorchis sinensis Abdominopelvic problems due to heavy clonorchiosis 0.123
Fasciola spp. Abdominopelvic problems due to heavy fasciolosis 0.123
Intestinal flukes c Abdominopelvic problems due to heavy intestinal fluke infections 0.123
Opisthorchis spp. Abdominopelvic problems due to heavy opisthorchiosis 0.123
Paragonimus spp. Central nervous system problems due to heavy paragonimosis 0.420
Pulmonary problems due to heavy paragonimosis 0.132
Organic pollutants
Dioxin Infertility 0.056
Hypothyroidy due to prenatal exposure 0.019
Hypothyroidy due postnatal exposure 0.019
Toxins and allergens
Aflatoxin Hepatocellular carcinoma: diagnosis and primary therapy 0.294
Hepatocellular carcinoma: metastatic 0.484
Hepatocellular carcinoma: terminal phase with medication 0.508
Hepatocellular carcinoma: terminal phase without medication 0.519
Cyanide in cassava Konzo 0.065
Peanut allergens b Living with peanut-induced allergy 0.012
a The disability weights for diarrheal disease were defined as a weighted average of the disability weights for mild, moderate and severe diarrhea, with
different relative contributions of these severity levels leading to different weighted averages for different diarrheal disease agents.
b Excluded from global burden assessments.
c Includes Echinostoma spp., Fasciolopsis buski, Heterophyes spp., Metagonimus spp. and other foodborne intestinal trematode species.
doi:10.1371/journal.pone.0142498.t001
WHO/FERGMethodological Framework
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epidemiological trends [20]; (2) is more consistent with the hazard-based approach, since it
has the point of infection (or primary health effect from exposure) as starting point for the cal-
culations; and (3) is more consistent with the estimation of YLLs, which by definition follows
an incidence-based approach, as mortality can be seen as the incidence of death [21]. Neverthe-
less, the prevalence- and incidence-based approaches yield similar overall results if the epide-
miology of disabilities and the population age-structure are constant over time [20]. However,
burden estimates for specific age groups will always differ between the prevalence- and inci-
dence-based approaches, because the former assigns the burden to the age at which the burden
is experienced, while the latter assigns the burden to the age of disease onset [15].
CTF Structure andWorkflow
Fig 1 shows a schematic overview of the CTF workflow. The CTF structure is defined around
the six distinctive components of this workflow, i.e., outline of disease models and collection of
epidemiological data; design of a database template; development of an imputation model;
identification of disability weights; probabilistic burden assessment; and source attribution of
Fig 1. Computational Task Force workflow.CTF = Computational Task Force; YLDs = Years Lived with Disability; YLLs = Years of Life Lost due to
mortality; DALYs = Disability-Adjusted Life Years; UNWPP 2012 = United Nations World Population Prospects 2012 Revision.
doi:10.1371/journal.pone.0142498.g001
WHO/FERGMethodological Framework
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the disease burden. All computations were implemented in R version 3.2.0 [22], and the vari-
ous functions were compiled in the R package 'FERG', which is available as Supporting Infor-
mation to this manuscript (S1 File) and online at https://github.com/brechtdv/FERG.
Disease models and epidemiological data
The starting point of the CTF workflow was the outline of disease models for each of the
included hazards (as chosen by the hazard-based task forces), and the epidemiological data
inputs that parameterized these disease models. To obtain this information, systematic reviews
were commissioned and managed by three hazard-based task forces, i.e., the Enteric Diseases
Task Force (EDTF), the Parasitic Diseases Task Force (PDTF), and the Chemicals and Toxins
Task Force (CTTF). Details are therefore provided elsewhere [23–25].
The course of disease is characterized by various health states (e.g. acute or chronic phases,
short-term or long-term sequelae), possibly having different severity levels [8]. A disease
model, also referred to as an outcome tree, is a schematic representation of the various health
states associated with the concerned hazard, and the possible transitions between these states.
A disease model for each hazard was defined by the members and commissioned experts of
each hazard-based task force, considering relevant health outcomes supported by evidence
identified in the respective reviews. Discussions of the choices and uncertainties in deriving the
disease models for specific hazards are provided elsewhere [23–25].
In the context of the CTF, disease models were defined as computational disease models,
and not merely as biological disease models. While biological disease models merely reflect the
natural history of disease, computational disease models also reflect the input parameters
needed to calculate incidence and mortality of each of the concerned health states. As such,
computational disease models are a combination of disease biology and data availability.
Computational disease models may be represented as directed acyclic graphs, defined by
parent and child nodes and directed edges (arrows) defining the relationships between nodes.
In the CTF framework, parent nodes were either incidence, mortality, YLD or YLL rates, while
child nodes were multiplicative elements, such as proportions or ratios (reflecting e.g. the prob-
ability of developing a specific symptom following infection, or the proportion of illnesses
attributable to the concerned hazard). A specific disease model "language" was developed to
denote the relationship and contribution of the different nodes. Rectangles defined parent
nodes, and rounded rectangles defined child nodes. Grey nodes did not contribute directly to
the DALYs, green nodes contributed YLDs, and red nodes contributed YLLs. Nodes that con-
tributed to the incidence of the index disease were identified by a thick border. S1 Fig gives the
disease models for all 36 FERG hazards.
In general, three main approaches can be distinguished for estimating the burden due to a
specific hazard in food, i.e., categorical attribution, counterfactual analysis, and risk assessment.
S1 Table gives an overview of the modelling strategy applied for each included hazard. As the
choice of the modelling strategy was mainly driven by the type of data available, no sensitivity
analyses could be performed to triangulate different modelling approaches. Modelling choices
were further driven by a strive for consistency with existing WHO Global Health Estimates.
Categorical attribution can be used when a foodborne hazard results in an outcome (death
or a specific syndrome) that is identifiable as caused by the hazard in individual cases [26]. Fol-
lowing the typology of Devleesschauwer et al. [16], the burden due to a specific hazard can
then be calculated using an attributional model (in which the incidence of the symptom is mul-
tiplied with the attributable proportion for a given hazard) or a transitional model (in which
the incidence of infection with or exposure to the hazard is multiplied with the probability of
developing a given symptom). Categorical attribution was applicable for all viral, bacterial and
WHO/FERGMethodological Framework
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parasitic hazards, and for cyanide in cassava and peanut allergens, and was therefore the stan-
dard method used by FERG. Fig 2 shows the computational disease model forMycobacterium
bovis, which is characteristic for the attributional models. In this model, the overall incidence
and mortality of tuberculosis is multiplied with the proportion attributable toM. bovis, result-
ing in the incidence and mortality ofM. bovis tuberculosis. Fig 3 shows the computational dis-
ease model for Echinococcus granulosus, which is characteristic for the transitional models. In
this model, the overall incidence of infection by this parasite was multiplied with child nodes
reflecting the probability of developing the concerned health states, resulting in the incidences
of the specific health states.
When the hazard elevates the risk of a disease or disability outcome that occurs in the popu-
lation from other causes as well, causal attribution can only be made statistically, and not on an
individual basis. This is the case for many chemicals, including aflatoxin and dioxin. Aflatoxin
for instance may increase the risk of hepatocellular carcinoma, but it is not possible to specify
that a specific liver cancer case was caused by aflatoxin. In this situation, the standard approach
for calculating the burden of environmental exposures is to use a counterfactual analysis in
which the current disease outcomes with current exposure are compared to the disease out-
comes under an alternate exposure (a minimum risk exposure which could be zero, or some
Fig 2. Computational disease model forMycobacterium bovis. Rectangles define parent nodes, while rounded rectangles defined child nodes. Green
nodes contribute Years Lived with Disability, and red nodes contribute Years of Life Lost. Nodes contributing to the incidence of the index disease are
identified by a thick border. INC = country-specific incidence; PROB–local = country-specific probability.
doi:10.1371/journal.pone.0142498.g002
WHO/FERGMethodological Framework
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accepted background level) [27]. This allows calculation of a population attributable fraction
(PAF) that can be applied to the all-cause burden estimates for the relevant disease outcome
(the so-called burden envelope), leading to a special case of the attributional model [16]. In the
context of FERG, counterfactual analysis was used to estimate the burden of aflatoxin-related
hepatocellular carcinoma.
In addition to categorical attribution and counterfactual analysis, which can be considered
top-down approaches, FBD burden can also be estimated by a risk assessment approach, which
can be considered a bottom-up approach. In this approach, the incidences of the specific health
states (e.g. impaired male fertility due to prenatal dioxin exposure) are estimated by combining
exposure and dose-response data. The dose-response model may for instance define the proba-
bility of illness at a given exposure level, which can then be translated into an estimate of the
number of incident or prevalent cases expected to occur in the exposed population [25,27]. As
this approach does not involve burden attribution, it does not necessarily ensure consistency
with existing health statistics. However, risk assessment may be a valid alternative when no
burden envelopes exist or when it can be demonstrated that the estimated excess risk is additive
to the background risk. In the context of FERG, risk assessment was used to estimate the bur-
den of dioxin-related hypothyroidy and impaired fertility.
CTF database template
A database template was developed in Excel (Microsoft Corp., Redmond, Washington, USA)
to collect the data resulting from the systematic reviews in a standardized way (S2 File). The
structure of the database was based on the disease models, with one sheet per node. Three
generic sheets were defined: (1) a "RATE" sheet, for rates by country; (2) a "PROB-local" sheet,
Fig 3. Computational disease model for Echinococcus granulosus. Rectangles define parent nodes, while rounded rectangles defined child nodes. Grey
nodes do not contribute directly to the DALYs, green nodes contribute YLDs, and red nodes contribute YLLs. Nodes contributing to the incidence of the index
disease are identified by a thick border. INC = country-specific incidence; PROB–global = probability applied to all countries; CE = cystic echinococcosis;
CNS = central nervous system.
doi:10.1371/journal.pone.0142498.g003
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for proportions or ratios by country; and (3) a "PROB-global" sheet, for a single proportion or
ratio that applied to all countries.
Each sheet consisted of four tables for entering (1) the rate or proportion/ratio data; (2) the
age distribution; (3) the sex distribution; and (4), if applicable, the duration. Using a drop-
down menu, different formats could be selected for entering the input parameters, including a
mean and 95% confidence interval; a minimum, most likely and maximum; different percen-
tiles; the shape and rate of a Gamma distribution (for rates); and the shape parameters of a
Beta distribution (for proportions). Gamma and Beta distributions were chosen because their
domains correspond to those of rates and proportions, respectively, and because their parame-
ters have an intuitive interpretation (i.e., number of cases and sample size or observation time,
respectively, number of positives and number of negatives). Likewise, different levels of stratifi-
cation could be selected for the duration parameters (i.e., none, by age only, by sex only, by age
and sex). Age distribution, sex distribution and duration were allowed to vary by country, by
defining different "groups" and assigning countries to "groups". Full details on the parameters
used for quantifying the burden of the different hazards is available in the appendices to the
EDTF, PDTF and CTTF manuscripts [23–25].
Imputation
Extrapolation or imputation models may be needed when literature searches cannot provide
essential epidemiological data such as incidence or mortality rates [28]. These models estimate
parameters based on data of neighboring regions or other time periods. The external data used
must thus be representative of the selected population, region and time. The CTF developed,
tested and evaluated several possible approaches to impute missing incidence data at the coun-
try level [29]. This exercise identified several pitfalls in the use of explanatory covariates, such
as the potential for overfitting and the arbitrariness in the selection of covariates. Therefore,
and further motivated by a strive for parsimony and transparency, we decided to use a log-Nor-
mal random effects model as the default model for imputing missing country-level incidence
data. We used the subregions as defined in Table 2 as the random effect or cluster variable.
This model assumes that the log-transformed incidence rate in country j belonging to subre-
gion i arises from a Normal distribution with subregion specific mean μi and a within-region
(= between-country) variance s2w. Each subregion specific mean μi is in turn assumed to arise
from a Normal distribution with mean μ0 and a between-region variance s2b:
logðyijÞ  Normalðmi; s2wÞ
mi  Normalðm0; s2bÞ
After fitting this hierarchical random effects model to the available data, incidence values
for countries with no data were imputed based on the resulting posterior predictive distribu-
tions. In other words, we represented missing incidence data by log-Normal distributions
based on the fitted mean and variance parameters. For countries in a subregion where none of
the countries had data, the log-incidence was imputed as multiple random draws from a Nor-
mal distribution with mean equal to the fitted global intercept μ0 and variance equal to the sum
of the fitted between-region variance s2b and the fitted within-region variance s
2
w (thus imput-
ing the log-incidence as that of a “random” country within a “random” subregion, with the
WHO/FERGMethodological Framework
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uncertainty interval describing the variability between and within subregions):
logðyijÞ  Normalðm0; s2b þ s2wÞ
For countries in a subregion where at least one of the other countries had data, the log-inci-
dence was imputed as multiple random draws from a Normal distribution with mean equal to
the fitted region-specific intercept μi and variance equal to the fitted within-region variance s2w
Table 2. World Health Organization (WHO) Member States by subregion.
Subregiona WHO member states
AFR D Algeria; Angola; Benin; Burkina Faso; Cameroon; Cape Verde; Chad; Comoros; Equatorial
Guinea; Gabon; Gambia; Ghana; Guinea; Guinea-Bissau; Liberia; Madagascar; Mali;
Mauritania; Mauritius; Niger; Nigeria; Sao Tome and Principe; Senegal; Seychelles; Sierra
Leone; Togo.
AFR E Botswana; Burundi; Central African Republic; Congo; Côte d'Ivoire; Democratic Republic of
the Congo; Eritrea; Ethiopia; Kenya; Lesotho; Malawi; Mozambique; Namibia; Rwanda;
South Africa; Swaziland; Uganda; United Republic of Tanzania; Zambia; Zimbabwe.
AMR A Canada; Cuba; United States of America.
AMR B Antigua and Barbuda; Argentina; Bahamas; Barbados; Belize; Brazil; Chile; Colombia; Costa
Rica; Dominica; Dominican Republic; El Salvador; Grenada; Guyana; Honduras; Jamaica;
Mexico; Panama; Paraguay; Saint Kitts and Nevis; Saint Lucia; Saint Vincent and the
Grenadines; Suriname; Trinidad and Tobago; Uruguay; Venezuela (Bolivarian Republic of).
AMR D Bolivia (Plurinational State of); Ecuador; Guatemala; Haiti; Nicaragua; Peru.
EMR B Bahrain; Iran (Islamic Republic of); Jordan; Kuwait; Lebanon; Libyan Arab Jamahiriya;
Oman; Qatar; Saudi Arabia; Syrian Arab Republic; Tunisia; United Arab Emirates.
EMR D Afghanistan; Djibouti; Egypt; Iraq; Morocco; Pakistan; Somalia; South Sudanb; Sudan;
Yemen.
EUR A Andorra; Austria; Belgium; Croatia; Cyprus; Czech Republic; Denmark; Finland; France;
Germany; Greece; Iceland; Ireland; Israel; Italy; Luxembourg; Malta; Monaco; Netherlands;
Norway; Portugal; San Marino; Slovenia; Spain; Sweden; Switzerland; United Kingdom.
EUR B Albania; Armenia; Azerbaijan; Bosnia and Herzegovina; Bulgaria; Georgia; Kyrgyzstan;
Montenegro; Poland; Romania; Serbia; Slovakia; Tajikistan; The Former Yugoslav Republic
of Macedonia; Turkey; Turkmenistan; Uzbekistan.
EUR C Belarus; Estonia; Hungary; Kazakhstan; Latvia; Lithuania; Republic of Moldova; Russian
Federation; Ukraine.
SEAR B Indonesia; Sri Lanka; Thailand.
SEAR D Bangladesh; Bhutan; Democratic People's Republic of Korea; India; Maldives; Myanmar;
Nepal; Timor-Leste.
WPR A Australia; Brunei Darussalam; Japan; New Zealand; Singapore.
WPR B Cambodia; China; Cook Islands; Fiji; Kiribati; Lao People's Democratic Republic; Malaysia;
Marshall Islands; Micronesia (Federated States of); Mongolia; Nauru; Niue; Palau; Papua
New Guinea; Philippines; Republic of Korea; Samoa; Solomon Islands; Tonga; Tuvalu;
Vanuatu; Viet Nam.
a The subregions are defined on the basis of child and adult mortality as described by Ezzati et al. [49].
Stratum A: very low child and adult mortality, Stratum B: low child mortality and very low adult mortality,
Stratum C: low child mortality and high adult mortality, Stratum D: high child and adult mortality, and
Stratum E: high child mortality and very high adult mortality. The use of the term “subregion” here and
throughout the text does not identify an official grouping of WHO Member States, and the “subregions” are
not related to the six official regions. AFR = African Region; AMR = Region of the Americas;
EMR = Eastern Mediterranean Region; EUR = European Region; SEAR = South-East Asia Region;
WPR = Western Pacific Region.
b South Sudan was reassigned to the African Region in May 2013. As this study relates to time periods
prior to this date, estimates for South Sudan were included in the Eastern Mediterranean Region.
doi:10.1371/journal.pone.0142498.t002
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(thus imputing the log-incidence as that of a “random” country within the concerned subre-
gion, with the uncertainty interval describing the variability within subregions):
logðyijÞ  Normalðmi; s2wÞ
When countries were considered free from exposure through the food chain, they were
excluded from the imputation model and thus did not contribute to the subregional estimates.
This was the case for Brucella spp., as discussed in [23], and Echinococcus granulosus, as dis-
cussed in [24]. For countries with available incidence data, no imputation was performed. The
incidence data used in the probabilistic burden assessments were thus a combination of actual
data and imputed estimates. No additional step was included to correct incidence data for
potential underreporting, as this was already captured by the previous steps of the framework.
Indeed, for the hazards that used an attributional model, disease envelopes were used that had
already been corrected for underreporting, while for other hazards we directly drew on GBD
2010 estimates (S1 Table). For the remaining hazards, either epidemiological data were used
that did not need (further) correction, or the underreporting factor was included in the disease
model (which was the case for Trichinella spp. and cyanide in cassava).
For aflatoxin, the same random effects model was used to extrapolate PAFs, but now using
logit-transformed instead of log-transformed values.
The model was implemented in a Bayesian framework, using independent Normal(0, 1e5)
priors for μ0 and all μi; a Uniform(0, 10) prior for σw; and a Folded-t(1) prior for σb, as sug-
gested by Gelman [30]. Sensitivity analyses using Gamma priors for the variance parameters
did not yield meaningful differences. The model was run in JAGS [31] through the 'rjags' pack-
age in R [32]. After a burn-in of 5000 iterations, another 5000 iterations were retained for infer-
ence. Two chains were run, and convergence was ascertained through density and trace plots,
and the multivariate potential scale reduction factor (or Brooks-Gelman-Rubin diagnostic).
The applied JAGS code is given in S1 Code.
A crucial assumption made by this imputation model is that missing data were considered
"missing at random" (MAR), meaning that missingness was independent of the unobserved
data, given the observed data [33,34]. In our case, this assumption implied that, within each
subregion, countries with data provided unbiased information on those without data, and that,
across subregions, subregions with data provided unbiased information on those without data.
For five hazards (Bacillus cereus, Clostridium perfringens, Clostridium botulinum, Staphylococ-
cus aureus, and peanut allergens), however, only data from high-income subregions, i.e., subre-
gions A or B, could be retrieved. In those instances, the assumption of MAR was clearly
violated, and it was decided not to extrapolate those data to the rest of the world. As a result,
those hazards were excluded from the global burden of disease estimates [35].
S1 Table shows which imputation strategy was used for each of the included hazards. For
the four intoxications, peanut allergens, and cyanide in cassava, the default random effects
model was not used because of the limited number of data points. Instead, the burden for each
concerned country was imputed as draws from a Uniform distribution defined by the lowest
and highest globally observed incidence or mortality rates. To ensure consistency with results
of the Child Health Epidemiology Reference Group (CHERG), alternative imputation
approaches were applied for estimating etiological fractions for the eleven diarrheal agents
[23,36,37]. For six other hazards, no imputation had to be performed because data were used
that had already been imputed. This was the case for hepatitis A virus, Salmonella Typhi, Sal-
monella Paratyphi, and Taenia solium, for which GBD 2010 data were used, and forMycobac-
terium bovis and Trichinella spp., for which other published data were used [38,39].
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Disability weights
DALYs incorporate the severity of health states through the DW, reflecting the corresponding
relative reduction in health on a scale from zero to one. DWs for several health states have
been derived for the GBD studies and for various national burden of disease studies [40]. To
ensure comparability, the CTF adopted the DWs that were used for WHO's Global Health Esti-
mates [15]. These DWs were based on those derived for the GBD 2010 study [41], but with an
alternative value for primary infertility (i.e., 0.056 instead of 0.011). The latter revision was
motivated by an analysis showing that the GBD 2010 weights undervalued the health states
associated with infertility [15]. For dioxin-induced hypothyroidy, we adopted the GBD 2013
DW for hypothyroidy, as this health state was not included in the GBD 2010 DW study [42].
Several FBDs present with unique clinical signs for which no DWs have been derived. Acute
trichinellosis, for instance, typically presents with myalgia and facial edema, for which no spe-
cific DWs are available [39]. When DWs were missing, proxy health states were selected by a
medical expert and DW expert in the CTF and confirmed by disease experts in the hazard spe-
cific task forces. In other instances, DWs were available for severity levels that were not explic-
itly considered in the disease models. For diarrhea, for instance, DWs were available for mild,
moderate and severe diarrhea, although the disease models only included diarrhea as such. In
those cases, weighted averages were calculated based on published reviews of severity distribu-
tions, avoiding an over- or underestimation of YLDs that would occur if only one DW would
have been selected. Table 1 lists the DWs used for the different FERG health states; S2 Table
provides further details on their derivation.
Probabilistic burden assessment
For each hazard, incidence, mortality, YLD, YLL and DALY rates were calculated for 11 age
groups (<1; 1–4; 5–14; 15–24; 25–34; 35–44; 45–54; 55–64; 65–74; 75–84;85) and both
sexes. When necessary, age and sex specific rates were obtained by multiplying the overall rates
with outcome specific age and sex distributions. The reference year for the calculation of abso-
lute numbers was 2010, with population estimates obtained from the 2012 revision of the
United Nations World Population Prospects [43]. All estimates were generated per country,
and subsequently aggregated per subregion, per region, and globally (Table 2). The resulting
estimates are presented in three hazard-specific papers [23–25] and in a summary paper [35].
The results may also be accessed and explored through an online tool (https://extranet.who.
int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G36/PROD/EXT/
FoodborneDiseaseBurden), which shows the breadth and flexibility of our framework in terms
of aggregating and reporting estimates.
The duration component of the YLDs is defined as the average observed duration until the
next health state (e.g., remission or death). For calculating YLDs when duration was lifelong,
we therefore used the country-specific life expectancy (LE) [43] as duration. The YLLs, on the
other hand, are essentially calculated as the number of cause-specific deaths multiplied by a
loss function specifying the years lost for deaths as a function of the age at which death occurs
[15]. In standard DALY methodology, the time component of the YLLs is defined as the ideal
residual life expectancy a person would have if the world would be free from disease and pro-
vide maximal access to health care. In accordance with the WHO Global Health Estimates, we
used the highest projected LE for 2050 as normative LE for calculating YLLs [15]. This LE table
has a LE at birth of 92, higher than that of the LE tables used in the GBD studies, which were
based on current death rates [13,14]. Since even for the lowest observed death rates there are a
proportion of deaths which are preventable or avertable, the highest projected LE for the year
2050 was deemed to better represent the maximum life span of an individual in good health,
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while acknowledging that it may still not represent the ultimate achievable human life span
[15]. In line with current global burden of disease assessments, no age weighting or time dis-
counting was applied [14,15]. HIV infected invasive salmonellosis cases and deaths, and HIV
infectedM. bovis deaths, were excluded from the burden estimates. No further corrections
were made for possible co-morbidities.
Parameter uncertainty was taken into account by performing the burden assessments in a
probabilistic framework. Ten thousand Monte Carlo (parametric bootstrap) simulations of the
input parameters were generated to calculate 10,000 estimates of incidence, mortality, YLD,
YLL and DALY rates. These 10,000 estimates were then summarized by their median and a
95% uncertainty interval defined as the 2.5th and 97.5th percentile of the distribution of esti-
mates. Special care was taken to deal with correlated uncertainties, for instance when the dis-
ease model included "global" probabilities (e.g. when it was assumed that the probability of
developing a certain health state following infection was the same for each country). In such
cases, a vector of random probabilities was simulated only once and applied to the different
countries, instead of incorrectly simulating a new, independent vector of random probabilities
for each country.
Source attribution
The main aim of FERG was to quantify the disease burden resulting from foodborne exposure
to potentially foodborne hazards. However, many of the hazards considered are not transmit-
ted solely by food, but have several potential exposure routes (e.g. direct contact with animals,
human-to-human transmission, and waterborne transmission). For certain hazards, it was
therefore necessary to attribute a proportion of their overall burden to foodborne exposure (S1
Table).
Some hazards were considered 100% foodborne, i.e., Listeria monocytogenes,M. bovis, all
foodborne trematodes, T. solium, Trichinella spp., aflatoxin, cyanide in cassava, dioxin and
peanut allergens.
For the remaining hazards, a structured expert elicitation using Cooke's Classical Method
was conducted to attribute burden to different exposure routes, providing hazards-specific esti-
mates for each exposure route per subregion [44]. This process yielded a probabilistic estimate
of the proportion foodborne, in the form of an empirical cumulative density function from
which random samples could be drawn. Foodborne cases, deaths, YLDs, YLLs and DALYs
were then obtained by multiplying the vectors of random values for these parameters with a
vector of random values for the proportion foodborne. As before, the perfect correlation of
uncertainty was dealt with by simulating only one vector of random foodborne proportions
per subregion, and by applying this vector to all parameters of all countries within the con-
cerned subregion.
Traceability and Transparency
The process described above was conducted in an iterative way, in which FERG members and
disease experts were given the opportunity to review and comment on preliminary results. Per
iteration, a time-stamped PDF report was generated containing the most relevant outputs, and
shared through an online file hosting service. When needed, teleconferences were organized to
resolve outstanding issues. A dedicated teleconference was organized to explain the imputation
model, its assumptions and limitations. In June 2014, a face-to-face meeting was held in which
the methods were reviewed and preliminary results were discussed with all FERG task force
members.
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Discussion
This paper reviewed the methodological framework developed to generate the first systematic
quantification of the global burden of FBDs. Details are provided on the underlying methods
and assumptions, and tools have been made available for the reader to explore and use. Burden
of foodborne disease estimates from these calculations are provided in the papers from the haz-
ard-based task forces.
Although our framework is the first framework for quantifying the global burden of FBDs,
other methodological frameworks for estimating global burden have been developed, most
notably the Global Burden of Cancer study [45] and the Global Burden of Disease study 2010
and 2013 [14,46]. Compared with these efforts, we present a framework that is centered on the
quantification of input parameter uncertainty, and in which modelling plays a minimal role.
By retaining the link between the input data (and their uncertainties) and the outputs, our
framework provides the opportunity to identify regions and hazards with the most uncertain
data, highlighting areas for further research in order to produce more accurate and precise bur-
den data. As such, the FERG philosophy builds on that of the Dutch burden of foodborne dis-
ease studies [18] and the Burden of Communicable Diseases in Europe (BCoDE) study [8,19],
but expands the scope by being more comprehensive in terms of hazards and geographical cov-
erage, and by adding data imputation and source attribution to the framework.
To overcome the inevitable problem of missing data, we imputed missing data using a hier-
archical random effects model as a default. Although the use of explanatory covariates such as
eating habits or income levels is often considered in these exercises, we decided not to pursue
such models driven by our earlier model evaluations and comparisons [29]. The choice of our
default imputation model was further motivated by a strive for parsimony and transparency,
while recognizing that other approaches could be used for stand-alone studies. Our imputation
model furthermore assumed that missing data were MAR, i.e., that, across subregions and
within each specific subregion, disease incidence and missingness were not associated [33,34].
This is a strong assumption, and led to the exclusion of five hazards for which the assumption
was clearly violated, i.e., Bacillus cereus, Clostridium perfringens, Clostridium botulinum, Staph-
ylococcus aureus, and peanut allergens. For the remaining hazards, it is difficult to evaluate the
validity of this assumption, as this would require a comparison of incidence data in countries
with data versus countries without data, which per definition is not possible [29]. As a result,
this assumption is made in all global burden of disease studies, even though this is not always
explicitly mentioned.
For countries in subregions without any data, our model resulted in relatively large uncer-
tainty intervals, as these took into account both variability between and within subregions. Of
the 14 hazards that used the random effects imputation model, SEAR B was the subregion for
which most often no data could be identified (i.e., for 4 hazards), followed by AMR A, AMR D
and SEAR D (for 2 hazards each) (S3 Table). At a country-level, Cambodia was the country
with the highest number of data gaps (i.e., for 10 hazards) (Fig 4).
A major limitation of the current framework is that it does not provide for modelling time
trends in disease burden. However, the main objective of FERG was to estimate, for the first time,
the global burden of FBDs. This sets a baseline against which future trends can be evaluated.
We excluded HIV infected invasive salmonellosis cases and deaths, and HIV infectedM.
bovis deaths, from the burden estimates. We did not correct for other co-morbidities, although
some foodborne hazards, such as Listeria, are often linked with co-morbidities such as cancer
or diabetes [47]. Some authors have corrected DALYs for co-morbidities by applying a reduced
LE [18]. In the GBD 2010 and GBD 2013 studies, which used a prevalence perspective for esti-
mating YLDs, comorbidities were taken into account by assuming conditional independence
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between disease prevalences and a multiplicative model for combining DWs [48]. Similar
methods have not yet been described for incidence-based YLDs.
No DWs were available for some FBD outcomes; these had to be mapped to proxy health
states for which DWs were available. When DWs were available for distinct severity levels,
over- or underestimation of the burden was avoided by using weighted averages based on pub-
lished reviews of severity distributions.
By quantifying the burden of 36 foodborne hazards in a single framework, we generated
comparable estimates and avoided overestimation which is typical for single-cause burden
studies [3]. For diarrheal hazards, we avoided overestimation by using multi-cause studies to
derive etiological fractions and by applying an established diarrhea envelope [36]. Attributional
models were also used for tuberculosis due toM. bovis, epilepsy due to T. solium and hepatocel-
lular carcinoma due to aflatoxin, ensuring consistency with the respective burden envelopes.
For the burden due to Ascaris spp., hepatitis A virus, Salmonella Typhi, and Salmonella Paraty-
phi, we directly drew on GBD 2010 estimates. For the remaining hazards, however, in absence
of well-accepted envelopes or sufficient scientific evidence on etiological fractions, attributional
models could not be applied. Instead, either a transitional model or a risk assessment approach
was applied, using the best possible data available (S1 Table). Inevitably, however, this might
have led to over- or underestimations compared to attributional models.
Conclusion
We developed a unique methodological framework for estimating the global burden of FBDs,
in which methodological simplicity and transparency are key elements. It would be
Fig 4. Number of imputed hazards byWHOmember state.
doi:10.1371/journal.pone.0142498.g004
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recommended to transform the current tools into a user-friendly national toolkit for estimating
and monitoring food safety at the local level. Such a toolkit could incorporate FERG estimates
such as source attribution, so that countries lacking such data can still estimate the burden of
foodborne diseases.
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